SCHEMBL7517465

SCHEMBL7517465

CC1=NCCc2ccc([N+](=O)[O-])cc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 4/20 0.44
ALDH1A1 P00352 3/20 0.44
MAPT P10636 3/20 0.44
GAA P10253 2/20 0.44
KDM4E B2RXH2 1/20 0.44
TDP1 Q9NUW8 2/20 0.43
TSHR P16473 2/20 0.43
PTPRC P08575 1/20 0.42
S100A4 P26447 1/20 0.42
PNMT P11086 4/20 0.42
ADRA2A P08913 2/20 0.42
MEN1 O00255 1/20 0.42
LMNA P02545 1/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 1/20 0.42
TLR9 Q9NR96 1/20 0.42
CYP3A4 P08684 2/20 0.41
TDP2 O95551 1/20 0.40
HTR1A P08908 1/20 0.40
DRD1 P21728 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8603671 0.93 ALDH1A1 (0.44) MAOAALDH1A1MAPTGAAKDM4E
SCHEMBL29869130 0.82 PTPRC (0.44) ALDH1A1MAPTGAATDP1TSHR
SCHEMBL28321486 0.81 PTPRC (0.42) ALDH1A1MAPTGAAKDM4ETDP1
SCHEMBL11617411 0.81 MAPT (0.47) ALDH1A1MAPTGAAKDM4ETDP1
SCHEMBL426337 0.81 HSD17B10 (0.43) ALDH1A1MAPTGAATDP1PTPRC
Hydrochloric Acid SCHEMBL7506677 0.81 PTPRC (0.42) MAPTGAAPTPRCS100A4PNMT
SCHEMBL5777991 0.81 PLAU (0.42) MAPTGAAPTPRCS100A4PNMT
SCHEMBL7513554 0.79 KDM4E (0.41) ALDH1A1MAPTGAAKDM4EPTPRC
SCHEMBL6181379 0.76 PTPRC (0.50) ALDH1A1MAPTGAAKDM4ETDP1
SCHEMBL15435590 0.75 HTR1D (0.46) ALDH1A1MAPTTDP1TSHRADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007048070-A2 PYRROLO-PYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES AMGEN INC. (US) 2007-04-26 WO disclosed
EP-0861250-B1 AMIDINE AND ISOTHIOUREA DERIVATIVES AS INHIBITORS OF NITRIC OXIDE SYNTHASE ASTRAZENECA AB (SE) 2002-02-13 EP disclosed
US-6277861-B1 FOR TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISORDERS, PSYCHOLOGICAL DISORDERS, MUSCULAR DISORDERS, DRUG ADDICTION WITHDRAWAL, PAIN SMITHKLINE BEECHAM, P.L.C. (GB) 2001-08-21 US disclosed
US-6140322-A Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase ASTRA AKTIEBOLAG (SE) 2000-10-31 US disclosed
EP-0971897-A1 ANTI-CONVULSANT ISOQUINOLYL-BENZAMIDE DERIVATIVES SMITHKLINE BEECHAM PLC (GB) 2000-01-19 EP disclosed
US-5929085-A Amidine and isothiourea derivatives, compositions containing them and their use as inhibitors of nitric oxide synthase ASTRA AKTIEBOLAG (SE) 1999-07-27 US disclosed
WO-1998041507-A1 ANTI-CONVULSANT ISOQUINOLYL-BENZAMIDE DERIVATIVES SMITHKLINE BEECHAM PLC (GB) 1998-09-24 WO disclosed
EP-0861250-A1 AMIDINE AND ISOTHIOUREA DERIVATIVES AS INHIBITORS OF NITRIC OXIDE SYNTHASE Astra Aktiebolag (SE) 1998-09-02 EP disclosed
US-5789595-A ANTICOAGULANTS TERUMO KABUSHIKI KAISHA (JP) 1998-08-04 US disclosed
CN-1167485-A Tetrahydroisoquinoline derivative and medicinal preparation containing the same TERUMO CORP (JP) 1997-12-10 CN disclosed
EP-0790247-A1 TETRAHYDROISOQUINOLINE DERIVATIVE AND MEDICINAL PREPARATION CONTAINING THE SAME TERUMO KABUSHIKI KAISHA (JP) 1997-08-20 EP disclosed
WO-1997017344-A1 AMIDINE AND ISOTHIOUREA DERIVATIVES AS INHIBITORS OF NITRIC OXIDE SYNTHASE ASTRA AKTIEBOLAG (SE) 1997-05-15 WO disclosed